<DOC>
	<DOCNO>NCT01488279</DOCNO>
	<brief_summary>The investigator hypothesize sitagliptin significantly reduce impairment insulin secretion insulin resistance result short-term oral glucocorticoid therapy .</brief_summary>
	<brief_title>Effect Sitagliptin Short-Term Metabolic Dysregulation Oral Glucocorticoid Therapy</brief_title>
	<detailed_description>The investigator plan conduct prospective , randomize , double-blind , placebo-controlled parallel arm study compare insulin secretion insulin resistance subject impair fast glucose oral glucocorticoid therapy + placebo versus subject oral glucocorticoid therapy + sitagliptin . For oral glucocorticoid therapy , plan use dexamethasone ( dex ) 2.5 mg daily . We choose dex know glycemic effect , improve compliance , daily dosing . Previous study show human , glucocorticoid-induced insulin resistance develop within 4 hour infuse drug high dose ( methylprednisolone 500 mg x single infusion ) change duration drug therapy 3 months.10 Furthermore , modest dose short duration ( dex 2.0 mg orally daily x 2 day ) show decrease insulin-mediated glucose disposal.11 12 Thus , study acute effect oral dex 2.5 mg daily x 7 day adequate achieve impair glucose-mediated insulin secretion impair insulin-mediated glucose disposal . In order sitagliptin desire effect , drug administer least 7 day ( 5 half-lives plus 40 % margin error ) . We plan study subject impair fast glucose impair glucose tolerance would likely candidate DPP-IV therapy future would likely impaired insulin secretion impair glucose disposal amenable DPP-IV therapy .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Men woman impair fast glucose We stratify weight age . Known Type 2 DM Severe disease prevent participation study On chronic steroid reason Already take DPP4 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Pre-diabetes</keyword>
	<keyword>Impaired fasting glucose</keyword>
	<keyword>Impaired glucose tolerance</keyword>
	<keyword>Steroid-induced hyperglycemia</keyword>
</DOC>